U lcerative colitis (UC), characterized by chronic inflammation of the colon and rectum, is one of the major forms of inflammatory bowel disease (IBD) worldwide and is a cause of significant morbidity in the afflicted population. 1 Although significant advances have been made in the medical treatment of UC in recent years, many patients still require colectomy for medically refractory disease, development of colon cancer or dysplasia, or inability to tolerate medical therapy due to side effects/complications. 2, 3 In fact, it is estimated that nearly 20% of UC patients eventually need colectomy. 4 Restorative proctocolectomy with ileal pouch anal anastomosis (IPAA) has become the standard of care in UC patients requiring surgical treatment and can significantly improve the patients' quality of life. 4, 5 However, complications after IPAA, such as pouchitis, cuffitis, bone loss, vitamin D deficiency, anemia, and nephrolithiasis, are frequently encountered in clinical practice. 4, [6] [7] [8] Our previous study showed that the prevalence of asymptomatic or symptomatic nephrolithiasis in patients with IPAA was 37%, 8 which is much higher than the estimated prevalence of 8.8% among the general population. 9 Speculated mechanisms including increased alkaline fluid loss as a result of frequent bowel movements leading to metabolic acidosis, acidic urine, decreased urinary citrate, and subsequent calcium and uric acid (UA) nephrolithiasis have been previously proposed. 8 We hypothesize that IPAA patients with nephrolithiasis have serum and urinary metabolic changes predisposing them to develop UA, calcium oxalate (CaOx), and/or calcium phosphate (CaP) stones. However, the exact pathogenesis of nephrolithiasis, especially the associated serum and urine metabolic changes which predispose to stone formation in these patients, remains unclear.
The assessment of urine supersaturation has become a standard tool for the evaluation of pathogenesis and risk factor for renal stone formation. 10 Supersaturation is the presence of a salt in solution at a concentration above its own solubility. This supersaturated state is the driving force for crystal formation and corresponds with the mineral composition of stones passed by the patient. 10, 11 It is computed using a computer program, which uses thermodynamic stability constants to calculate free ion activities for urinary ions. These free ion activities are used to calculate the supersaturation ratio for the various solid phases. 12 The aims of this study were (1) to compare serum and urine metabolic 
PATIENTS AND METHODS

Study Subjects
Approval from our Institutional Review Board was obtained for this single-center cross-sectional study. Consecutive patients were enrolled in the study from the subspecialty pouchitis clinic at our institution between October 2011 and March 2016. Participation was completely voluntary, and verbal and written informed consent was obtained from all participants at the time of enrollment into the study.
Inclusion and Exclusion Criteria
Adult patients diagnosed with UC who had previously undergone restorative proctocolectomy with IPAA were eligible to be included into the study. Based on their history and imaging findings, patients were separated into the study group or the control group. The study group consisted of patients with a reported history of nephrolithiasis or with evidence of nephrolithiasis on imaging, whereas the control group consisted of patients without a history of nephrolithiasis and absence of nephrolithiasis on recent imaging (,6 mo).
Exclusion criteria were patients with (1) Kock pouch, Spouch, or W-pouch; (2) an ileal pouch for familial adenomatous polyposis; (3) history of nephrolithiasis before proctocolectomy; (4) a known history of intrinsic renal disorders known to be associated with increased risk of nephrolithiasis (e.g., polycystic kidney disease, medullary sponge kidney); (5) patients taking medications, which might increase the risk of nephrolithiasis (e.g., carbonic anhydrase inhibitors, topiramate); (6) a history of other systemic disorders known to be associated with nephrolithiasis (e. g., sarcoidosis, gout, primary hyperparathyroidism, multiple myeloma).
Demographic and Clinical Variables
Detailed demographic and clinical variables were collected, including age, gender, indication for colectomy, duration of UC before colectomy, extraintestinal manifestations, pouch diagnosis, and concurrent medications. For patients in the study group, history regarding symptoms and complications of nephrolithiasis and treatment received were also collected.
Laboratory Assays of Serum and Urine Specimens
At the conclusion of clinic visit, blood specimens were collected from all participants by the on-site laboratory for the measurement of serum sodium, potassium, chloride, blood urea nitrogen, creatinine, bicarbonate, calcium, phosphorus, parathyroid hormone, and 25-OH vitamin D levels by standard clinical assays.
Patients were also provided with a 24-hour urine collection kit containing urine collection aid, container, urine preservative bottle, small tube (for sending urine specimen), forms and instructions, prepaid FedEx mailing form, and a biological patient sample shipping box. Once the shipped 24-hour urine specimens were received from the patients, analyses for volume, pH, calcium, oxalate, phosphate, citrate, UA, magnesium, sodium, potassium, sulfate, ammonium, creatinine, and chloride were performed and supersaturation for UA, CaOx, and CaP was calculated using Equil2-a BASIC computer program by Litholink Laboratories (Chicago, IL). 12 
Outcomes
The primary outcome of the study was the comparison of urine and serum metabolic compositions between the study and control groups. The secondary outcomes were clinical sequelae of nephrolithiasis and association between urine panel and pouchrelated factors (such as the presence of pouchitis or CD of the pouch).
Sample Size Calculation
The sample size was estimated based on the previously published data indicating that patients with UC and IPAA had a mean 24-hour urine volume, pH, and citrate of 0.57 6 0.23 mL/ min, 5.19 6 0.35, and 231 6 161 mg/24 hours, respectively. 13 A difference of at least 30% between the groups was considered to be of clinical importance. Assuming similar variabilities in urine volume, pH, and citrate concentration, a total of 20 subjects per group were needed to ensure a power of 80% to detect a mean difference of at least 0.2 mL/min, 0.3, and 146 mg/24 hours in a 24-hour urine volume, pH, and citrate, respectively, at a significance level of 0.05.
Statistical Analyses
Data are presented as mean 6 SD, median (25th, 75th percentiles), or frequency (percentage). A univariable analysis was performed to assess differences between subjects with and without kidney stones. Analysis of variance or the nonparametric Kruskal-Wallis tests were used to compare continuous factors, and Pearson's chi-square test or Fisher's exact test was used for categorical variables. A P value of ,0.05 was considered statistically significant. P values were not adjusted for multiple comparisons. All analyses were performed using SAS (version 9.4, The SAS Institute, Cary, NC).
RESULTS
A total of 40 subjects were included in the analysis, 20 in the study group and 20 in the control group. Table 1 presents a summary of the demographic and clinical characteristics of the patients. Overall, there was no significant difference between the study group and the control group in terms of age, gender, history of smoking or alcohol use, and family history of IBD, colon cancer, or nephrolithiasis. Patients were also similar in terms of the extent of UC, duration of UC before colectomy, and indication for surgery. However, patients in the study group were less likely to have extraintestinal manifestations of UC (20% versus 50%, P ¼ 0.047). Patients in the study group also had a longer median duration between IPAA creation and enrollment than control group (157.5 versus 88.5 mo, P ¼ 0.04). There were no significant differences between the study and control groups in terms of complications of the pouch, such as acute or chronic pouchitis, CD of the pouch, or irritable pouch syndrome.
Information regarding symptoms and complications of nephrolithiasis for the study group is presented in Table 2 . A majority of the patients were symptomatic at the time of diagnosis of nephrolithiasis. Presenting symptoms included abdominal pain in 19 (95%) patients and pyelonephritis in 2 (10%) patients. Several patients required procedural intervention for treatment of nephrolithiasis, including ureteroscopy in 3 (15%) patients, lithotripsy in 5 (25%) patients, and percutaneous surgery in 1 (5%) patient. Table 3 presents a summary of the differences in serum and urinary laboratory testing between the study and control groups. Overall, no significant differences were observed in the levels of serum electrolytes, vitamin D, parathyroid hormone, and renal function tests between the study and control groups. However, in urinary testing, patients in the study group were found to have a significantly higher 24-hour urine supersaturation of CaOx (8.8 versus 5.0, P ¼ 0.037) and CaP (0.61 versus 0.27, P ¼ 0.028) compared with controls (Fig. 1) . The 24-hour urine volume and citrate were numerically lower among patients in the study group versus controls, but this was not statistically significant (0.91 versus 1.3 L, P ¼ 0.15, and 279 versus 285.5 mg, P ¼ 0.81, respectively).
DISCUSSION
Restorative proctocolectomy with IPAA has become the corner stone of surgical therapy for UC patients. Although it can significantly improve the patients' quality of life, complications remain common with morbidity rates as high as 60% described in the literature. 14 Nephrolithiasis is a common complication after IPAA and has been observed in over a third of patients being followed at a tertiary care center (Fig. 2) . 8 The present study investigated the risk factors for nephrolithiasis in these patients and the pathogenetic changes in the serum and urine, which predispose to stone formation. We found that patients with nephrolithiasis had significantly higher 24-hour urine supersaturation of CaOx (8.8 versus 5.0, P ¼ 0.037) and CaP (0.61 versus 0.27, P ¼ 0.028) as compared with those without nephrolithiasis, even though there were no significant differences in the levels of serum electrolytes. Nephrolithiasis has been well described in patients with IBD, and multiple studies seem to indicate an increased risk for nephrolithiasis in these patients over the general population. [15] [16] [17] [18] [19] [20] [21] [22] [23] The reported rates of nephrolithiasis in UC patients range between 0.2% and 11% for surgery-naive patients and 8.4% and 40% for patients with total colectomy and ileostomy. [16] [17] [18] 22 Among CD patients, reported rates range from 4% to 5.5% for surgery-naive patients and 15% to 30% for those with a history of small bowel resection. 17, 22, 23 Our previous study showed a prevalence of nephrolithiasis of 37% among IPAA patients. 8 Several mechanisms have been proposed to account for the increased risk for nephrolithiasis. In patients with small bowel resection, bile acid malabsorption due to impaired enterohepatic circulation results in steatorrhea. The resulting intraluminal free fatty acids compete with dietary oxalate for binding with calcium. As calcium gets bound to fatty acids, increased levels of free oxalate become available and are absorbed from the colon, subsequently resulting in hyperoxaluria and oxalate stone formation. 23, 24 Additionally, decreased gut colonization with Oxalobacter formigenes, an oxalate-metabolizing bacteria, has been reported in IBD patients, which results in impaired oxalate catabolism, hyperoxaluria, and subsequent stone formation. [25] [26] [27] It is also important to note that the rate of absorption of dietary oxalate increases from the duodenum to the colon, with colon being the site of absorption of majority of dietary oxalate. 28 For these reasons, oxalate stones are seen more commonly in patients with small bowel resection and less commonly in patients with colectomy. 29 In contrast, in UC patients with ileostomy, increased gastrointestinal loss of alkaline fluids due to the absence of a functioning colon leads to dehydration and metabolic acidosis. To compensate for these metabolic derangements, kidneys reabsorb more water, sodium, and bicarbonate, thereby resulting in decreased urinary pH and volume. Additionally, magnesium losses from the gut lead to decreased levels of urinary magnesium, which is an important inhibitor of crystallization in the urine. The resultant effect of all these changes is an increased risk of UA nephrolithiasis, which is seen more frequently in these patients than in the general population. 18, 19, 23 This is because UA is far less soluble in the resulting concentrated acidic urine as compared with dilute alkaline urine, so much so that a decrease in urine pH from 7 to 5 results in a decrease in solubility of UA from 200 to 15 mg/dL. 30, 31 However, the types of stones in UC patients with IPAA have not been well characterized. In our previous study, we had described the risk factors for nephrolithiasis in these patients. 8 These include the presence of extraintestinal manifestations, no use of antibiotics, and low serum bicarbonate level. However, due to the retrospective nature of that study, information regarding the metabolic changes in these patients, especially the urinary supersaturation for CaOx, CaP, and UA, had not been available. Through this follow-up study, we have demonstrated that UC patients with IPAA who developed nephrolithiasis had increased urinary supersaturation of CaOx and CaP. This is in contrast to UC patients with ileostomy who tend to develop UA stones as discussed above.
Previous studies have shown that bacterial overgrowth is nearly universally present in the pouch and prepouch ileum. 32, 33 One of the results of bacterial overgrowth is the increased deconjugation of primary bile salts and accumulation of secondary bile salts in the pouch. 32 These secondary bile acids are poorly reabsorbed resulting in fecal loss of bile acids and gradual depletion of bile salt pool-a process which has been described as bile acid malabsorption type III. 32, 34, 35 Consequently, this results in steatorrhea and hyperoxaluria by mechanism similar to described above for patients with small bowel resection, ultimately resulting in oxalate kidney stones. The oxalate crystals then act as substrates over which subsequent deposition of CaP occurs resulting in mixed CaOx-CaP stones. 36, 37 We believe that this is the underlying mechanism of stone formation in pouch patients, which is further supported by our previous finding that nonuse of antibiotics is a risk factor for stone formation. 8 Our study has several clinical implications. Knowing the type of kidney stone in patients allows for recommendations to be made regarding dietary changes, which can decrease the risk of stone formation. For example, patients should be advised to eliminate or limit intake of oxalate-rich foods, such as dark green leafy vegetables, chocolates, strawberry, and tea. Additionally, a low-sodium diet can reduce calciuria because urinary calcium excretion is directly linked to the urinary excretion of sodium. The use of alkalinizing agents, such as potassium citrate, has also been advocated, as citrate inhibits the formation and growth of calcium crystals. 38 The urinary citrate concentration in our study, however, was not significantly different between cases and controls. Increased calcium intake, by binding to dietary oxalate, can decrease oxalate absorption and urinary excretion thereby decreasing the risk of nephrolithiasis. However, there have been recent concerns regarding increased cardiovascular risk with the use of calcium supplements. 39, 40 On the contrary, higher dietary calcium intake without use of calcium supplements has been associated with a decreased risk of atherosclerosis. As a result, the safest approach in these patients may be to increase dietary calcium intake from food sources without the use of supplements. Because dehydration is an important factor in CaOx and CaP supersaturation and stone formation, increased fluid intake of at least 2.5-3 L/d is key to preventing these stones. 38, 41 In our study, patients with nephrolithiasis had numerically lower 24-hour urine volume than controls, which further supports the importance of hydration, although this did not reach statistical significance. We also did not find any significant difference in the serum electrolytes, vitamin D, parathyroid hormone, and renal function between cases and controls, thereby indicating that these tests may be poor predictors for stone formation. In these patients, 24-hour urine analysis provides a more accurate estimation of risk of nephrolithiasis.
The present study has some limitations. The study population was enrolled from specialty Pouchitis Center at a tertiary IBD referral center, which may have introduced a referral bias. We did not have technical details of the initial pouch surgery in all patients as these were frequently done at other institutions. Patients in the study group had a significantly longer "age of pouch" as compared with controls. This could have potentially contributed to the differences in urine metabolic changes seen between the 2 groups. Also, due to the crosssectional study design, it was not possible to follow patients over time to see the time line of development of metabolic changes after IPAA surgery. A prospective cohort study may be better suited for that purpose and could help predict an individual patient's risk of nephrolithiasis over time. Additionally, this study was limited to patients who underwent IPAA surgery for UC. Although we believe that the results of this study are also applicable to patients who undergo IPAA surgery for other indications such as familial adenomatous polyposis because the pouch physiology remains similar, this cannot be definitively concluded from the present study.
In conclusions, our study demonstrates that UC patients with IPAA are at risk for development of CaOx and CaP stones due to increased urine supersaturation of CaOx and CaP. This is in contrast to patients with ileostomy where previous studies have demonstrated an increased risk of UA stones. Additionally, nephrolithiasis is symptomatic in a majority of patients and frequently requires procedural intervention for treatment.
